EUCAST Disc Diffusion Criteria for the Detection of MecA-Mediated β-lactam Resistance in Staphylococcus Pseudintermedius: Oxacillin Versus Cefoxitin
Overview
Authors
Affiliations
Objectives: Until recently, the European Committee on Antimicrobial Susceptibility Testing (EUCAST) recommended the cefoxitin disc to screen for mecA-mediated β-lactam resistance in Staphylococcus pseudintermedius. A recent study indicated that cefoxitin was inferior to oxacillin in this respect. We have re-evaluated cefoxitin and oxacillin discs for screening for methicillin resistance in S. pseudintermedius.
Methods: We included 224 animal and human S. pseudintermedius isolates from Europe (n = 108) and North America (n = 116), of which 109 were mecA-positive. Disc diffusion was performed per EUCAST recommendations using 30-μg cefoxitin and 1-μg oxacillin discs from three manufacturers and Mueller-Hinton agar from two manufacturers.
Results: Cefoxitin inhibition zones ranged from 6 to 33 mm for mecA-positive S. pseudintermedius (MRSP) and from 29 to 41 mm for mecA-negative S. pseudintermedius (MSSP). The corresponding oxacillin zone intervals were 6-20 mm and 19-30 mm. For cefoxitin 16% (95% CI 14.8-18.0%) of the isolates were in the area where positive and negative results overlapped. For oxacillin the corresponding number was 2% (1.6-2.9%). For oxacillin a breakpoint of susceptible (S) ≥ 20 mm and resistant (R) <20 mm resulted in only 0.4% and 1.1% very major error and major error rates respectively.
Conclusions: This investigation confirms that the 1-μg oxacillin disc predicts mecA-mediated methicillin resistance in S. pseudintermedius better than the 30-μg cefoxitin disc. For a 1-μg oxacillin disc we propose that 20 mm should be used as cut off for resistance, i.e. isolates with a zone diameter <20 mm are resistant to all β-lactam antibiotics except those with activity against methicillin-resistant staphylococci.
Putriningsih P, Kampa J, Jittimanee S, Phuektes P Animals (Basel). 2024; 14(17).
PMID: 39272398 PMC: 11394641. DOI: 10.3390/ani14172613.
Nocera F, De Martino L Vet Res Commun. 2024; 48(6):3505-3515.
PMID: 39167258 PMC: 11538175. DOI: 10.1007/s11259-024-10508-8.
Taponen S, Tolli H, Rajala-Schultz P Front Vet Sci. 2023; 10:1235417.
PMID: 37662993 PMC: 10470832. DOI: 10.3389/fvets.2023.1235417.
Hong S, Jiang W, Ding Q, Lin K, Zhao C, Wang X Int J Nanomedicine. 2023; 18:3761-3780.
PMID: 37457798 PMC: 10348378. DOI: 10.2147/IJN.S403882.
Khongsri U, Chongrattanameteekul P, Chantarachart S, Photichai K, Chanayat N, Varinrak T Life (Basel). 2023; 13(5).
PMID: 37240855 PMC: 10221572. DOI: 10.3390/life13051210.